The company expects revenues to between $33 million and $35 million, up from $12.1 million in the first quarter of 2014.
Historically, the company has produced approximately 14 percent of its annual revenue in the first quarter of the year.
More articles on transactions and valuation issues:
NAPA announces partnership with Virginia Eye Institute
Sentara Northern Virginia Medical Center to build $40M ASC
AmSurg stock rated at ‘buy’
